Leveraging its cutting-edge technology, Salignostics has launched three innovative saliva-based diagnostic products: Salistick, the only rapid saliva-based pregnancy test; SaliCov, a CE-approved COVID-19 rapid saliva test; and Salicomb, a CE-approved saliva collection and sample preparation device.
Salignostics is also in the final stages of developing a revolutionary Strep Throat Test to detect Group A Streptococcus (Strep A or GAS) bacteria, allowing easy self-testing without professional assistance. Looking ahead, Salignostics is expanding its technology to develop diagnostic tests for HIV, STIs, respiratory viruses, and other infectious diseases.
Salignostics operates a dedicated manufacturing facility in Israel, ensuring high standards for its advanced saliva-based diagnostic tests. This facility is purpose-built to support the company’s mission of making non-invasive, saliva-based testing widely accessible. Equipped to produce a full range of tests using Salignostics’ technology, the plant is ISO 13485 certified and has a production capacity of 1 million units per month, ensuring reliable supply to meet growing market demand.